Compounds > 11-hydroxy-n-(n-propyl)noraporphine
Page last updated: 2024-09-03

11-hydroxy-n-(n-propyl)noraporphine and 5-hydroxy-1-methyl-2-(di-n-propylamino)tetralin

11-hydroxy-n-(n-propyl)noraporphine has been researched along with 5-hydroxy-1-methyl-2-(di-n-propylamino)tetralin in 1 studies

Compound Research Comparison

Studies
(11-hydroxy-n-(n-propyl)noraporphine)		Trials
(11-hydroxy-n-(n-propyl)noraporphine)		Recent Studies (post-2010)
(11-hydroxy-n-(n-propyl)noraporphine)		Studies
(5-hydroxy-1-methyl-2-(di-n-propylamino)tetralin)		Trials
(5-hydroxy-1-methyl-2-(di-n-propylamino)tetralin)		Recent Studies (post-2010) (5-hydroxy-1-methyl-2-(di-n-propylamino)tetralin)
1102500

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baldessarini, RJ; Campbell, A; Froimowitz, M; Gao, YG; Neumeyer, JL1

Other Studies

1 other study(ies) available for 11-hydroxy-n-(n-propyl)noraporphine and 5-hydroxy-1-methyl-2-(di-n-propylamino)tetralin

ArticleYear
Neuropharmacology and stereochemistry of dopamine receptor agonist and antagonist enantiomeric pairs.
    Journal of receptor research, 1988, Volume: 8, Issue:1-4

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aporphines; Dopamine; Molecular Conformation; Naphthalenes; Piperidines; Receptors, Dopamine; Stereoisomerism; Structure-Activity Relationship; Tetrahydronaphthalenes

1988